ClinicalTrials.gg
Status unknownNCT01982409Updated Mar 27, 2014

Immune Persistence After Inoculated With One-dose Freeze-Dried Live Attenuated Varicella Vaccine in Children Vaccine in Children

A Phase 4 interventional study of Live Attenuated Varicella Vaccine in Chickenpox, sponsored by Changchun Changsheng Life Science and Technology Co., Ltd.. Status unknown at 1 site in China. Open to participants aged 1 Year to 6 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-03-27.

Sponsored by Changchun Changsheng Life Science and Technology Co., Ltd. · Phase 4, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Mar 2014), so the status shown — last known as Active, not recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 4
Study type
Interventional
Enrollment
350
Allocation
Not applicable
Ages
1 Year to 6 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 36 studies testing Chickenpox Vaccine in Chickenpox — 5 open to participants now, 7 under way, 4 of them phase 3. Chickenpox Vaccine · Chickenpox.

Enrollment
21st of 36
350 · median 404
Started
2013
with 3 others
Phase 4
14 of 36
2 open now
Registered
18th of 36
by date
Lead sponsor
1 of 36
Changchun Changsheng Life Science and Technology Co., Ltd.

Among the 36 studies testing Chickenpox Vaccine in Chickenpox, this one is the 21st largest by enrollment, is one of 4 that started in 2013, is one of 14 in phase 4, and was the 18th registered.

Chickenpox

180 studies on the registry are indexed under Chickenpox; 28 are open to participants now.

Browse Chickenpox studies →

Open to participants now

5 of the 36 studies testing Chickenpox Vaccine in Chickenpox are open now, in 7 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

About Chickenpox Vaccine

Chickenpox Vaccine: first FDA approval 1995 (Varivax). What it is approved for, and how studies give it, is on its page →

Who these studies take

Of the 16 Chickenpox studies recruiting now, 3 (19%) set no upper age limit and 13 (81%) stop at 75 or younger; 12 take children under 18; 13 take healthy volunteers.

This study: 1 Year to 6 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 36 studies testing Chickenpox Vaccine in Chickenpox, or all of them as a file.
02

Study summary

The purpose of this study is to observe the persistence of protection, duration of protection, safety and breakthrough infection rates afforded by live attenuated varicella vaccine in children over a 5-year period.

03

Conditions studied

  • Chickenpox

Browse trials for

04

Who can participate

Ages eligible
1 Year to 6 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participant are healthy children aged 1-6 years, who has inquired for medical history and physical examination, and met the requirement of the vaccine trial
  • Parent/legal acceptable representative is willing and able to understand the protocol requirements and provide
  • Subject and parent/guardian able to attend all scheduled visits and comply with all trial procedures
  • Body temperature ≤37℃

Exclusion criteria

Exclusion Criteria:

  • Participant with previous history of chickenpox or zoster
  • Receipt of varicella vaccine
  • Reported the family history of allergies, convulsions, epilepsy and mental illness
  • Known allergy to any constituent of the vaccine
  • Known serve illness, in a fever, acute infection and chronic disease activity
  • Receipt of
  • Reported the history of thrombocytopenia or other coagulation disorders, which may cause
  • Known or suspected impairment of immunologic function, or receipt of therapy or immunoglobulin since birth
  • Known congenital malformation, developmental disorders and severe chronic disease (e.g. Down's syndrome, diabetes, sickle cell anemia and neurologic disorders)
  • Known dermatopathy with allergy, herpes, fester, and fungal infection
  • Receipt of whole blood, blood plasma or immunoglobulin in the 3 months preceding the trial vaccination
  • Reported the history of acute illness had need systemic antibiotics or anti-viral treatment of infections in the 7 days preceding the trial vaccination
  • Participant with fever(temperature≥ 38℃) in the days
  • Any condition, which, in the opinion of the investigator, would pose a health risk to the subject
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Phase
Phase 4
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
350 participants (actual)

Study arms

  • Experimental
    Live Attenuated Varicella Vaccine

    use the arm flank deltoid muscle adheres to stick cohere place the skin after 75% ethyl alcohol disinfection the hypodermic injection

    Biological: Live Attenuated Varicella Vaccine

Interventions

06

What researchers measure

Primary outcomes

  1. Immune protective effect and persistence after inoculated with live attenuated varicella vaccine

    Clinical subjects are drawn 3ml's vein blood,respectively before vaccination, six weeks and every year in 5 years study period after inoculation of the live varicella vaccine. FAMA methods are used to test antibody rate of pox virus.

    Time frame: Before vaccination, six weeks and every year in 5 years study period after inoculation of the live varicella vaccine

Secondary outcomes

  1. Breakthrough rate, duration and severity of varicella in vaccinated children

    Time frame: 5 years period

  2. Occurrence of adverse events

    Time frame: Up to 4 weeks after vaccination

07

Study locations

1 site
  • Maoming Center for Disease Control and Prevention
    Maoming, Guangdong, China
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jun 2013, a primary completion of Jan 2018 and a completion of Dec 2018. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 24, 2013
First posted
Nov 13, 2013
Start
Jun 2013
Primary completionEst.
Jan 2018
CompletionEst.
Dec 2018
Last update
Mar 27, 2014
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 27, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01982409
Lead sponsor
Changchun Changsheng Life Science and Technology Co., Ltd.
Collaborators
Guangdong Provincial Institute of Biological Products And Materia Medica
Responsible party
Sponsor
First posted
Nov 13, 2013
Start date
Jun 2013
Primary completion
Jan 2018 (estimated)
Completion
Dec 2018 (estimated)
Last update
Mar 27, 2014

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Chickenpox Vaccine

Start the discussion